Topic: Metastatic hormone-sensitive PCa: new standards of care
Earn accreditation points
Finish 5 cases, answer 10 questions and Earn 1 credit.
This topic consists of 5 cases
Disease Area: Prostate cancer
Background: Guidelines on 1st- and 2nd-line treatment of patients with metastatic hormone-sensitive prostate cancer have recently changed due to new evidence from clinical studies.
Educational Objective: To study the new data and guidelines and learn to apply these in different patient cases.
Specialty: Urology, Medical oncology
Target Audience: CME (intermediate-advanced), Residents (senior)
Latest update: October 1, 2018